This company listing is no longer active
GABY Stock Overview
GABY Inc., together with its subsidiaries, produces, markets, sells, and retails cannabis-related consumer packaged goods in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
GABY Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.005 |
| 52 Week High | CA$0.01 |
| 52 Week Low | CA$0.005 |
| Beta | 1.03 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -50.00% |
| 33 Year Change | -93.75% |
| 5 Year Change | -98.59% |
| Change since IPO | -99.00% |
Recent News & Updates
Shareholder Returns
| GABY | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | 0.9% | -0.5% |
| 1Y | -50.0% | 15.7% | 23.2% |
Return vs Industry: GABY underperformed the Canadian Pharmaceuticals industry which returned -29.5% over the past year.
Return vs Market: GABY underperformed the Canadian Market which returned -0.7% over the past year.
Price Volatility
| GABY volatility | |
|---|---|
| GABY Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.9% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.4% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: GABY has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine GABY's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | n/a | n/a | www.gabyinc.com |
GABY Inc., together with its subsidiaries, produces, markets, sells, and retails cannabis-related consumer packaged goods in the United States. The company packages and markets various cannabis products, including flowers, concentrates, pre-rolls, edibles, topicals, tinctures, and other products derived from or infused with cannabis or hemp. It offers its cannabis products under the Mankind, HempFusion, Sagely Naturals, Apothecanna, Kind Republic, Lulu’s, 2Rise, and Dank Space brand names.
GABY Inc. Fundamentals Summary
| GABY fundamental statistics | |
|---|---|
| Market cap | CA$3.71m |
| Earnings (TTM) | -CA$43.28m |
| Revenue (TTM) | CA$27.98m |
0.1x
P/S Ratio-0.1x
P/E RatioIs GABY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GABY income statement (TTM) | |
|---|---|
| Revenue | US$20.73m |
| Cost of Revenue | US$10.75m |
| Gross Profit | US$9.98m |
| Other Expenses | US$42.05m |
| Earnings | -US$32.07m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.043 |
| Gross Margin | 48.16% |
| Net Profit Margin | -154.72% |
| Debt/Equity Ratio | -106.8% |
How did GABY perform over the long term?
See historical performance and comparison